Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04600973 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection

Study acronym: BASIC
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting Primary completion date: Jun 30, 2026 to Oct 30, 2026 · Completion date: Jun 30, 2026 to Dec 31, 2026 · Site details revised at 2 of 2 sitesv10 Show 3 more changesShow less
    • Primary completion date: Jun 30, 2026 to Oct 30, 2026
    • Completion date: Jun 30, 2026 to Dec 31, 2026
    • Site details revised at 2 of 2 sites
  2. 2 versions Re-verified since Oct 14, 2024, no change to tracked fieldsv8-v9
  3. Study sites revised (2) Collaborators revised (2)v7 Show 1 more changeShow less
    • Collaborators revised (2)

    See this version in full on ClinicalTrials.gov ↗

  4. Re-verified, no change to tracked fieldsv6
  5. Trial status: Active, Not Recruiting to Recruiting Site details revised at 2 of 2 sitesv5 Show 1 more changeShow less
    • Site details revised at 2 of 2 sites
Show 3 earlier versionsHide 3 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting Site details revised at 2 of 2 sitesv4 Show 1 more changeShow less
    • Site details revised at 2 of 2 sites
  2. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 2v3 Show 1 more changeShow less
    • Study sites: 0 to 2
  3. Enrollment target: 1500 to 6000 Eligibility criteria shortened, about 79 words · Study description expanded, about 5 wordsv2 Show 2 more changesShow less
    • Eligibility criteria shortened, about 79 words
    • Study description expanded, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Surgical site infections (SSIs) are associated with increased patient morbidity, mortality, and healthcare costs. ESKAPE (Enterococcus, S. aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) pathogens are particularly pathogenic because they have increased capacity to acquire resistance and virulence traits. The investigators have proven that a multifaceted program involving improved basic perioperative preventive measures can generate substantial reductions in S. aureus transmission and significant reductions in SSIs (88% reduction as compared to usual care). In this study, the investigators aim to examine the relative effectiveness of each component of this program in controlling ESKAPE transmission and reducing SSIs and to identify an optimal implementation strategy for national dissemination. Randomization occurs at the site level, and sites adopt preventative programs. This work will improve perioperative patient safety for the 51 million patients who undergo surgery each year.
Trial Details
NCT Number NCT04600973
Lead Sponsor Trustees of Dartmouth College
Collaborators: Mayo Clinic, Georgetown University
Conditions Infection
Enrollment 6,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov